Morning Briefing
Summaries of health policy coverage from major news organizations
Partial Solution Reached In NYC Nurse Contract Talks; Strike Still Looms
A possible strike by thousands of New York City nurses loomed Monday even as nurses at one hospital reached a tentative agreement hours before their contract was set to expire. The pact affecting 4,000 nurses at NewYork-Presbyterian Hospital awaits ratification. (1/2)
Also —
General Electric Co. will start 2023 by splitting off its healthcare unit, completing a key step in the slow-motion breakup of the industrial giant. For the rest of the year it will face questions about the next big step: shedding its power businesses. (Gryta, 1/2)
Gilead Sciences (GILD.O) will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics (JNCE.O) for $67 million, the drugmaker said on Tuesday. The amended licensing deal will bolster Jounce's cash resources in a challenging market for biotech companies. (12/29)
Novartis AG (NOVN.S) said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the United States of generic versions of its Exforge hypertension drug. (Stempel, 12/29)
In health care training news —
Amid an ongoing shortage of physicians in rural America, one health system and its academic medical partner are putting a new spin on two residency programs. (Berryman, 1/2)
Of all the things she could have done on her summer vacation, Bithaniya Fieseha, a senior at West Springfield High School in Fairfax County, Va., decided to study chronic disease, mental health and contact tracing. Some of her friends didn't understand the appeal. (Huang, 1/1)
